Medroxyprogesterone Acetate 150 mg/mL

Medroxyprogesterone Acetate 150 mg/mL is an extended-release injection used for contraception and hormone therapy. This suspension is administered intramuscularly and is manufactured by Amphastar Pharmaceuticals, Inc.

Medroxyprogesterone Acetate is primarily used for contraception and hormone replacement therapy. It works by altering the menstrual cycle to prevent ovulation, making it a popular choice for long-term birth control. Additionally, it may be used to manage symptoms associated with hormonal imbalances.

Common effects of Medroxyprogesterone Acetate may include changes in menstrual bleeding patterns, such as irregular periods or spotting. Some users may experience weight gain, headaches, or mood changes. These effects can vary widely among individuals.

Medroxyprogesterone Acetate should be used with caution in individuals with a history of blood clots, breast cancer, or liver disease. It is important to discuss your medical history with a healthcare provider before starting this medication. Always follow the prescribed dosage and administration instructions.

Medroxyprogesterone Acetate may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated while using this medication.